| Year |
Citation |
Score |
| 2021 |
Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, Ferrada MA, Wu Z, Gutierrez-Rodrigues F, Lotter J, Wilson L, Hoffmann P, Cardona DO, Patel N, Dulau-Florea A, ... ... Calvo KR, et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Advances. 5: 3203-3215. PMID 34427584 DOI: 10.1182/bloodadvances.2021004976 |
0.301 |
|
| 2020 |
Obiorah IE, Francischetti IMB, Wang HW, Ahn IE, Wang W, Raffeld M, Kreitman RJ, Wiestner A, Calvo KR. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features. Leukemia & Lymphoma. 1-11. PMID 32755330 DOI: 10.1080/10428194.2020.1797007 |
0.37 |
|
| 2020 |
Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Shen S, Ranheim EA, Kraus SG, Wang W, Calvo KR, Hsu AP, Holland SM, Coon JJ, Keles S, Bresnick EH. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. The Journal of Experimental Medicine. 217. PMID 32736380 DOI: 10.1084/Jem.20191526 |
0.368 |
|
| 2020 |
Wu Z, Gao S, Diamond C, Kajigaya S, Chen J, Shi R, Palmer C, Hsu AP, Calvo KR, Hickstein DD, Holland SM, Young NS. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency. Blood Advances. 4: 2656-2670. PMID 32556286 DOI: 10.1182/Bloodadvances.2019001352 |
0.407 |
|
| 2020 |
Vicente A, Patel BA, Gutierrez-Rodrigues F, Groarke E, Giudice V, Lotter J, Feng X, Kajigaya S, Weinstein B, Barranta E, Olnes MJ, Parikh AR, Albitar M, Wu CO, Shalhoub R, ... Calvo KR, et al. Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome. Haematologica. PMID 32439728 DOI: 10.3324/Haematol.2020.249995 |
0.381 |
|
| 2020 |
Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, Gutierrez-Rodrigues F, Lotter J, Valdez J, Sellers SE, Barranta ME, Shalhoub RN, Wu CO, Albitar M, Calvo KR, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Advances. 4: 1700-1710. PMID 32330244 DOI: 10.1182/Bloodadvances.2020001657 |
0.386 |
|
| 2020 |
Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang HW, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James L, Wilson W, Braylan RC, Calvo KR, Maric I, et al. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902250. PMID 32109194 DOI: 10.1200/Jco.19.02250 |
0.323 |
|
| 2020 |
Good ML, Malekzadeh P, Kriley IR, Shah NN, Kleiner DE, Calvo K, Hernandez JM, Davis JL. Intrahepatic cholangiocarcinoma as a rare secondary malignancy after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia: A case report. Pediatric Transplantation. e13653. PMID 31944498 DOI: 10.1111/Petr.13653 |
0.32 |
|
| 2019 |
McReynolds LJ, Zhang Y, Yang Y, Tang J, Mulé M, Hsu AP, Townsley DM, West RR, Zhu J, Hickstein DD, Holland SM, Calvo KR, Hourigan CS. Rapid progression to AML in a patient with germline mutation and acquired Q61K mutation. Leukemia Research Reports. 12: 100176. PMID 31245276 DOI: 10.1016/J.Lrr.2019.100176 |
0.362 |
|
| 2019 |
Galera P, Dulau-Florea A, Calvo KR. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia. International Journal of Laboratory Hematology. 41: 131-141. PMID 31069978 DOI: 10.1111/Ijlh.12999 |
0.386 |
|
| 2019 |
Espinoza DA, Fan X, Yang D, Cordes SF, Truitt LL, Calvo KR, Yabe IM, Demirci S, Hope KJ, Hong SG, Krouse A, Metzger M, Bonifacino A, Lu R, Uchida N, et al. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31023523 DOI: 10.1016/J.Ymthe.2019.04.003 |
0.373 |
|
| 2019 |
Winkler T, Fan X, Cooper J, Desmond R, Young DJ, Townsley DM, Scheinberg P, Grasmeder S, Larochelle A, Desierto M, Valdez J, Lotter J, Wu C, Shalhoub RN, Calvo KR, et al. Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution. Blood. PMID 30992268 DOI: 10.1182/Blood.2019000478 |
0.332 |
|
| 2019 |
McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, et al. Plerixafor for the Treatment of WHIM Syndrome. The New England Journal of Medicine. 380: 163-170. PMID 30625055 DOI: 10.1056/Nejmoa1808575 |
0.35 |
|
| 2019 |
McReynolds LJ, Yang Y, Yuen Wong H, Tang J, Zhang Y, Mulé MP, Daub J, Palmer C, Foruraghi L, Liu Q, Zhu J, Wang W, West RR, Yohe ME, Hsu AP, ... ... Calvo KR, et al. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. Leukemia Research. 76: 70-75. PMID 30578959 DOI: 10.1016/J.Leukres.2018.11.013 |
0.374 |
|
| 2019 |
Kallen ME, Dulau-Florea A, Wang W, Calvo KR. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications. Seminars in Hematology. 56: 69-82. PMID 30573048 DOI: 10.1053/J.Seminhematol.2018.05.016 |
0.355 |
|
| 2019 |
Dulau-Florea A, Maric I, Calvo KR, Braylan RC. Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates. Seminars in Hematology. 56: 65-68. PMID 30573047 DOI: 10.1053/J.Seminhematol.2018.05.011 |
0.378 |
|
| 2019 |
Hodes A, Calvo KR, Dulau A, Maric I, Sun J, Braylan R. The challenging task of enumerating blasts in the bone marrow. Seminars in Hematology. 56: 58-64. PMID 30573046 DOI: 10.1053/J.Seminhematol.2018.07.001 |
0.336 |
|
| 2019 |
Chihara D, Arons E, Stetler-Stevenson M, Yuan C, Zhou H, Raffeld M, Xi L, Steinberg SM, Wisch L, Feurtado J, James-Echenique L, Braylan R, Calvo KR, Maric I, Dulau A, et al. Randomized phase II study of cladribine with simultaneous or delayed rituximab in patients with untreated hairy cell leukemia. Journal of Clinical Oncology. 37: 7003-7003. DOI: 10.1200/Jco.2019.37.15_Suppl.7003 |
0.342 |
|
| 2019 |
Soukup A, Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Ranheim EA, Calvo KR, Hsu AP, Holland SM, Coon JJ, Keles S, Bresnick EH. GATA2-Dependent Developmental and Regenerative Networks Blood. 134: 1182-1182. DOI: 10.1182/Blood-2019-126875 |
0.357 |
|
| 2019 |
Wu Z, Gao S, Kajigaya S, Chen J, Shi R, Diamond C, Palmer C, Hsu AP, Calvo KR, Hickstein DD, Holland SM, Young NS. Single-Cell RNA Sequencing Reveals a Distinct Transcriptome Signature of Hematopoiesis in GATA2 Deficiency Blood. 134: 3735-3735. DOI: 10.1182/Blood-2019-124774 |
0.436 |
|
| 2019 |
Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang H, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James-Echenique L, Wilson W, Braylan RC, Calvo KR, Maric I, et al. Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant Blood. 134: 1536-1536. DOI: 10.1182/Blood-2019-124515 |
0.359 |
|
| 2018 |
Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, ... ... Calvo KR, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. PMID 30500073 DOI: 10.1002/Cncr.31896 |
0.377 |
|
| 2018 |
Galera P, Hsu AP, Wang W, Droll S, Chen R, Schwartz JR, Klco JM, Arai S, Maese L, Zerbe C, Parta MJ, Young NS, Holland SM, Hickstein DD, Calvo KR. Donor-derived MDS/AML in families with germline GATA2 mutation. Blood. PMID 30232126 DOI: 10.1182/Blood-2018-07-861070 |
0.361 |
|
| 2018 |
McReynolds LJ, Calvo KR, Holland SM. Germline GATA2 Mutation and Bone Marrow Failure. Hematology/Oncology Clinics of North America. 32: 713-728. PMID 30047422 DOI: 10.1016/J.Hoc.2018.04.004 |
0.373 |
|
| 2018 |
Dulau-Florea AE, Young NS, Maric I, Calvo KR, Dunbar CE, Townsley DM, Winkler T, Monreal M, Jiang C, Jordan EK, Braylan RC. Bone Marrow as a Source of Cells for Paroxysmal Nocturnal Hemoglobinuria Detection. American Journal of Clinical Pathology. PMID 29982419 DOI: 10.1093/Ajcp/Aqy053 |
0.329 |
|
| 2018 |
Boutboul D, Kuehn HS, Van de Wyngaert Z, Niemela JE, Callebaut I, Stoddard J, Lenoir C, Barlogis V, Farnarier C, Vely F, Yoshida N, Kojima S, Kanegane H, Hoshino A, Hauck F, ... ... Calvo KR, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. The Journal of Clinical Investigation. PMID 29889099 DOI: 10.1172/Jci98164 |
0.395 |
|
| 2018 |
Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, ... ... Calvo KR, et al. Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell. 173: 1439-1453.e19. PMID 29856956 DOI: 10.1016/J.Cell.2018.05.013 |
0.355 |
|
| 2018 |
Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, et al. Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase II study. Blood. PMID 29483101 DOI: 10.1182/Blood-2017-12-820910 |
0.334 |
|
| 2018 |
Parta M, Shah NN, Baird K, Rafei H, Calvo KR, Hughes T, Cole K, Kenyon M, Blacklock Schuver B, Cuellar-Rodriguez J, Zerbe CS, Holland SM, Hickstein DD. Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29412158 DOI: 10.1016/J.Bbmt.2018.01.030 |
0.339 |
|
| 2018 |
Vicente A, Gutierrez-Rodrigues F, Giudice V, Wu Z, Kajigaya S, Fernandez Ibanez MdP, Albitar M, Weinstein B, Calvo KR, Townsley DM, Scheinberg P, Dunbar CE, Young NS, Winkler T. Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS) Blood. 132: 229-229. DOI: 10.1182/Blood-2018-99-119780 |
0.399 |
|
| 2018 |
Scheiermann J, West R, Embree LJ, Calvo KR, Shah NN, Tuschong L, Parta M, Hickstein DD. Prognostic Value of IPSS-R Score, Cytogenetic Aberrations, and Cytopenias on Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Myelodysplastic Syndrome in GATA2 Deficiency Blood. 132: 3094-3094. DOI: 10.1182/Blood-2018-99-114874 |
0.384 |
|
| 2018 |
Fan X, Winkler T, Desmond R, Dumitriu B, Townsley DM, Fernandez Ibanez MdP, Gutierrez-Rodrigues F, Grasmeder S, Barranta ME, Madey D, Lotter J, Valdez J, Calvo KR, Wu C, Young NS, et al. Eltrombopag for Moderate Aplastic Anemia and Unilineage Cytopenias: Dosing, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling Blood. 132: 538-538. DOI: 10.1182/Blood-2018-99-112994 |
0.377 |
|
| 2018 |
Kazandjian D, Korde N, Mailankody S, Zhang Y, Hsu J, Hill E, Morrison C, Divakarla S, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Galera P, Dulau-Florea A, Salem D, ... ... Calvo KR, et al. A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term Deep Remissions and Prolonged Progression-Free Duration Regardless of Age or Cytogenetic Risk after 5 Years of Follow up Blood. 132: 1957-1957. DOI: 10.1182/Blood-2018-99-111712 |
0.344 |
|
| 2017 |
Bogaert DJ, Kuehn HS, Bonroy C, Calvo KR, Dehoorne J, Vanlander AV, De Bruyne M, Cytlak U, Bigley V, De Baets F, De Baere E, Rosenzweig SD, Haerynck F, Dullaers M. A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B cell maturation defects. The Journal of Allergy and Clinical Immunology. PMID 28927821 DOI: 10.1016/J.Jaci.2017.08.019 |
0.329 |
|
| 2017 |
Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Leukemia & Lymphoma. 1-9. PMID 28540748 DOI: 10.1080/10428194.2017.1321746 |
0.319 |
|
| 2017 |
Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, ... Calvo KR, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. The New England Journal of Medicine. 376: 1540-1550. PMID 28423296 DOI: 10.1056/Nejmoa1613878 |
0.38 |
|
| 2017 |
Schlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC, Allan DS, Davidson-Moncada JK, Dickinson RE, Holmes TD, Hsu AP, Townsley D, Winkler T, Wang W, Aukrust P, ... ... Calvo KR, et al. Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood. PMID 28209719 DOI: 10.1182/Blood-2016-08-734236 |
0.379 |
|
| 2017 |
Winkler T, Cooper JN, Townsley DM, Scheinberg P, Grasmeder S, Wu C, Lotter J, Desierto MJ, Desmond R, Olnes MJ, Calvo KR, Young NS, Dunbar CE. Eltrombopag for Refractory Severe Aplastic Anemia: Dosing Regimens, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling Blood. 130: 777-777. DOI: 10.1182/Blood.V130.Suppl_1.777.777 |
0.384 |
|
| 2017 |
Espinoza DA, Wu C, Fan X, Yang D, Yabe IM, Demirci S, Hong SG, Bonifacino A, Krouse A, Metzger M, Lu R, Calvo KR, Tisdale JF, Wu X, Ravin SSD, et al. Aberrant Clonal Hematopoiesis of the Erythroid and Myeloid Lineages in a Lentivirally Barcoded Rhesus Macaque Blood. 130: 606-606. DOI: 10.1182/Blood.V130.Suppl_1.606.606 |
0.328 |
|
| 2016 |
Dulau Florea AE, Braylan RC, Schafernak KT, Williams KW, Daub J, Goyal RK, Puck JM, Rao VK, Pittaluga S, Holland SM, Uzel G, Calvo KR. Abnormal B-Cell Maturation in the Bone Marrow of Patients with Germline Mutations in PIK3CD. The Journal of Allergy and Clinical Immunology. PMID 27697496 DOI: 10.1016/J.Jaci.2016.08.028 |
0.361 |
|
| 2016 |
Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, ... ... Calvo KR, et al. Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone. Leukemia & Lymphoma. 1-10. PMID 27687480 DOI: 10.1080/10428194.2016.1214953 |
0.344 |
|
| 2016 |
Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, ... ... Calvo KR, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Jci Insight. 1. PMID 27588307 DOI: 10.1172/Jci.Insight.88782 |
0.379 |
|
| 2016 |
Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. The Journal of Allergy and Clinical Immunology. PMID 27130863 DOI: 10.1016/J.Jaci.2016.03.016 |
0.305 |
|
| 2016 |
Kuehn HS, Boisson B, Cunningham-Rundles C, Reichenbach J, Stray-Pedersen A, Gelfand EW, Maffucci P, Pierce KR, Abbott JK, Voelkerding KV, South ST, Augustine NH, Bush JS, Dolen WK, Wray BB, ... ... Calvo KR, et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. The New England Journal of Medicine. 374: 1032-1043. PMID 26981933 DOI: 10.1056/Nejmoa1512234 |
0.37 |
|
| 2016 |
Kazandjian D, Korde NS, Roschewski M, Mailankody S, Morrison C, Manasanch EE, Kwok ML, Tageja N, Bhutani M, Zingone A, Costello R, Zhang Y, Mulquin M, Lamping L, Carpenter A, ... ... Calvo KR, et al. Sustained Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R): Updated Results of a Phase 2 Study Blood. 128: 4527-4527. DOI: 10.1182/Blood.V128.22.4527.4527 |
0.373 |
|
| 2016 |
Anastas V, Wang W, Price S, Zhao Z, Rao VK, Calvo KR. Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations Blood. 128: 4268-4268. DOI: 10.1182/Blood.V128.22.4268.4268 |
0.339 |
|
| 2016 |
Kazandjian D, Korde NS, Roschewski M, Mailankody S, Morrison C, Manasanch EE, Kwok ML, Tageja N, Bhutani M, Zingone A, Costello R, Zhang Y, Mulquin M, Lamping L, Carpenter A, ... ... Calvo KR, et al. Sustained High Rates of Complete Response and Minimal Residual Disease Negativity after 8 Cycles of Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R) in Patients with High-Risk Smoldering Multiple Myeloma: Updated Results of Clinical and Correlative Phase 2 Study Blood. 128: 3339-3339. DOI: 10.1182/Blood.V128.22.3339.3339 |
0.361 |
|
| 2016 |
Goswami M, Oetjen K, Mulé MP, Sheela S, Wong HY, Liu Q, Calvo KR, Lai CE, Hourigan CS. Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults Blood. 128: 1644-1644. DOI: 10.1182/Blood.V128.22.1644.1644 |
0.377 |
|
| 2015 |
Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Jones J, Wong DH, et al. Disruption of in vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib - findings from an investigator initiated phase 2 study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26660519 DOI: 10.1158/1078-0432.Ccr-15-1965 |
0.302 |
|
| 2015 |
Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, ... ... Calvo KR, et al. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma. Jama Oncology. PMID 26181891 DOI: 10.1001/Jamaoncol.2015.2010 |
0.343 |
|
| 2015 |
Niemela J, Kuehn HS, Kelly C, Zhang M, Davies J, Melendez J, Dreiling J, Kleiner D, Calvo K, Oliveira JB, Rosenzweig SD. Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings. Journal of Clinical Immunology. 35: 348-55. PMID 25814141 DOI: 10.1007/S10875-015-0150-8 |
0.368 |
|
| 2015 |
Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, Rao VK. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 125: 2753-8. PMID 25691160 DOI: 10.1182/Blood-2014-11-567917 |
0.359 |
|
| 2015 |
Goswami M, McGowan KS, Lu K, Jain N, Candia J, Hensel NF, Tang J, Calvo KR, Battiwalla M, Barrett AJ, Hourigan CS. A multigene array for measurable residual disease detection in AML patients undergoing SCT. Bone Marrow Transplantation. 50: 642-51. PMID 25665046 DOI: 10.1038/Bmt.2014.326 |
0.354 |
|
| 2015 |
McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, ... ... Calvo KR, et al. Chromothriptic cure of WHIM syndrome. Cell. 160: 686-99. PMID 25662009 DOI: 10.1016/J.Cell.2015.01.014 |
0.391 |
|
| 2015 |
Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, ... ... Calvo KR, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. The Lancet. Oncology. 16: 169-76. PMID 25555420 DOI: 10.1016/S1470-2045(14)71182-9 |
0.316 |
|
| 2015 |
Ganapathi KA, Townsley DM, Hsu AP, Arthur DC, Zerbe CS, Cuellar-Rodriguez J, Hickstein DD, Rosenzweig SD, Braylan RC, Young NS, Holland SM, Calvo KR. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 125: 56-70. PMID 25359990 DOI: 10.1182/Blood-2014-06-580340 |
0.43 |
|
| 2015 |
Townsley DM, Dumitriu B, Scheinberg P, Desmond R, Feng X, Rios O, Weinstein B, Valdez J, Winkler T, Desierto M, Leuva H, Wu C, Calvo KR, Larochelle A, Dunbar CE, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia Accelerates Count Recovery and Increases Response Rates Blood. 126: LBA-2-LBA-2. DOI: 10.1182/Blood.V126.23.Lba-2.Lba-2 |
0.361 |
|
| 2015 |
Yang Y, Zhang Y, Zhu J, Lai CE, Tang J, McReynolds LJ, Hsu AP, Hickstein DD, Townsley DM, Holland SM, Calvo KR, Hourigan CS. Development of Somatic NRAS Mutation Associated with Rapid Transition from Germline GATA2 Mutation Associated Myelodysplastic Syndrome to Acute Myeloid Leukemia Blood. 126: 3616-3616. DOI: 10.1182/Blood.V126.23.3616.3616 |
0.395 |
|
| 2015 |
Giannelou AA, Zhou Q, Stoffels M, Ombrello A, Stone D, Edwan J, Pelletier M, Tsai W, Calvo K, Rosenzweig S, Barron K, Gadina M, Aksentijevich I, Daniel L, Kastner D. A2.35 TRNT1missense mutations define a new periodic fever syndrome Annals of the Rheumatic Diseases. 74: A30.1-A30. DOI: 10.1136/Annrheumdis-2015-207259.70 |
0.339 |
|
| 2015 |
Hsu A, Townsley D, DeSierto M, Hickstein D, Calvo K, Holland S, Young N. 46 HIGH FREQUENCY OF GATA2 MUTATIONS IN APLASTIC ANEMIA AND HYPOCELLULAR MYELODYSPLASTIC SYNDROME Leukemia Research. 39: S21. DOI: 10.1016/S0145-2126(15)30047-3 |
0.345 |
|
| 2015 |
Bryke CR, McDermott DH, Gao J, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, ... ... Calvo KR, et al. WHIM Syndrome Cured by Chromothripsis Cancer Genetics. 208: 358-359. DOI: 10.1016/J.Cancergen.2015.05.007 |
0.324 |
|
| 2015 |
Ganapathi KA, Schafernak KT, Rao VK, Calvo KR. Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases Journal of Hematopathology. 8: 159-167. DOI: 10.1007/S12308-015-0250-7 |
0.34 |
|
| 2014 |
Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, Hughes T, Hakim F, Cole K, Parta M, Freeman A, Holland SM, Hickstein DD. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1940-8. PMID 25111582 DOI: 10.1016/J.Bbmt.2014.08.004 |
0.364 |
|
| 2014 |
Zingone A, Wang W, Corrigan-Cummins M, Wu SP, Plyler R, Korde N, Kwok M, Manasanch EE, Tageja N, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Roschewski M, Zhang Y, ... ... Calvo KR, et al. Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease. Cytokine. 69: 294-7. PMID 25043675 DOI: 10.1016/J.Cyto.2014.05.017 |
0.355 |
|
| 2014 |
Herman SE, Niemann CU, Farooqui M, Jones J, Mustafa RZ, Lipsky A, Saba N, Martyr S, Soto S, Valdez J, Gyamfi JA, Maric I, Calvo KR, Pedersen LB, Geisler CH, et al. Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia. 28: 2188-96. PMID 24699307 DOI: 10.1038/Leu.2014.122 |
0.393 |
|
| 2014 |
McDermott DH, Liu Q, Velez D, Lopez L, Anaya-O'Brien S, Ulrick J, Kwatemaa N, Starling J, Fleisher TA, Priel DA, Merideth MA, Giuntoli RL, Evbuomwan MO, Littel P, Marquesen MM, ... ... Calvo KR, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 123: 2308-16. PMID 24523241 DOI: 10.1182/Blood-2013-09-527226 |
0.309 |
|
| 2014 |
Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, et al. Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases Leukemia Research. 38: 371-376. PMID 24462038 DOI: 10.1016/J.Leukres.2013.12.007 |
0.325 |
|
| 2014 |
Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 123: 1818-25. PMID 24345753 DOI: 10.1182/Blood-2013-10-534743 |
0.373 |
|
| 2014 |
Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 123: 809-21. PMID 24227816 DOI: 10.1182/Blood-2013-07-515528 |
0.349 |
|
| 2014 |
Ghafoor A, Calvo KR, Corrigan-Cummins M, Simakova O, Costello R, Yuan C, Stetler-Stevenson M, Korde N, Roschewski MJ, Landgren O, Maric I. Immunophenotypic profiles of plasma cells and tumor burden in patients with smoldering myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS). Journal of Clinical Oncology. 32: e19589-e19589. DOI: 10.1200/Jco.2014.32.15_Suppl.E19589 |
0.303 |
|
| 2014 |
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski MJ, Mulquin M, Lamping E, Weiss BM, Mena E, Lindenberg L, Calvo KR, et al. Focal bone marrow processes and early bone lesions in patients with multiple myeloma (MM) precursor diseases: A prospective study using molecular imaging. Journal of Clinical Oncology. 32: 8587-8587. DOI: 10.1200/Jco.2014.32.15_Suppl.8587 |
0.305 |
|
| 2014 |
Jesus AAD, Montealegre G, Liu Y, Marrero B, Kuehn H, Calvo K, Rosenzweig S, Fleisher T, Lee RC, Brundidge A, Chapelle D, Huang Y, Brooks S, Moir S, Meffre E, et al. A de novo nonsense mutation in the tyrosine kinase lyn in a patient with an early onset autoinflammatory phenotype. Pediatric Rheumatology. 12: 1-2. DOI: 10.1186/1546-0096-12-S1-O25 |
0.3 |
|
| 2014 |
Goswami M, McGowan KS, Lu K, Jain NA, Candia J, Hensel NF, Tang J, Calvo KR, Battiwalla M, Barrett AJ, Hourigan CS. A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation Blood. 124: 667-667. DOI: 10.1182/Blood.V124.21.667.667 |
0.395 |
|
| 2014 |
Spinner MA, Odio C, Calvo KR, Hsu AP, Zerbe CS, Cuellar-Rodriguez J, Ker JP, Stoudenmire CJ, Fadare O, Ghosh A, Mace EM, Orange JS, Hickstein DD, Holland SM. Hemophagocytic Lymphohistiocytosis Associated with NK Cell Dysfunction and Disseminated Herpesvirus Infection in GATA2 Deficiency/Monomac Syndrome Blood. 124: 4978-4978. DOI: 10.1182/Blood.V124.21.4978.4978 |
0.395 |
|
| 2014 |
Landgren O, Roschewski M, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Zingone A, Costello R, Burton D, Zhang Y, Wu P, Carter G, Mulquin M, ... ... Calvo KR, et al. Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Final Results from the NCI Phase 2 Pilot Study Blood. 124: 4746-4746. DOI: 10.1182/Blood.V124.21.4746.4746 |
0.382 |
|
| 2014 |
Dulau Florea AE, Braylan RC, Schafernak KT, Pittaluga S, Holland SM, Uzel G, Calvo KR. Abnormal B-Cell Maturation Pattern in the Bone Marrow of Patients with Germline Mutations in PIK3CD Blood. 124: 2752-2752. DOI: 10.1182/Blood.V124.21.2752.2752 |
0.332 |
|
| 2014 |
Korde N, Mailankody S, Roschewski M, Faham M, Kotwaliwale C, Moorhead M, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Costello R, Zhang Y, Zingone A, Burton D, ... ... Calvo KR, et al. Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities Blood. 124: 2105-2105. DOI: 10.1182/Blood.V124.21.2105.2105 |
0.332 |
|
| 2014 |
Sokolic RA, Chonat S, Risinger M, Eckhaus M, Garabedian E, Calvo KR, Maric I, Kalfa TA, Candotti F. Cation Leak in Red Blood Cells of Patients with Wiskott-Aldrich Syndrome Leads to Non-Immunologic Hemolysis Blood. 124: 1338-1338. DOI: 10.1182/Blood.V124.21.1338.1338 |
0.368 |
|
| 2014 |
Cuellar-Rodriguez J, Hickstein DD, Grossman JK, Parta M, Gea-Banacloche J, Zerbe CS, Freeman AF, Holland SM, Calvo KR. Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency Blood. 124: 1247-1247. DOI: 10.1182/Blood.V124.21.1247.1247 |
0.35 |
|
| 2013 |
Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M. Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6873-81. PMID 24277451 DOI: 10.1158/1078-0432.Ccr-13-1752 |
0.358 |
|
| 2013 |
Bat T, Steinberg SM, Childs R, Calvo KR, Barrett AJ, Battiwalla M, Baird K, Zhang D, Pulanic D, Dunbar CE, Pavletic SZ. Active thrombopoiesis is associated with worse severity and activity of chronic GVHD. Bone Marrow Transplantation. 48: 1569-73. PMID 23832091 DOI: 10.1038/Bmt.2013.95 |
0.314 |
|
| 2013 |
Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 964-72. PMID 23531552 DOI: 10.1038/Mt.2013.34 |
0.358 |
|
| 2013 |
Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC. Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Molecular & Cellular Proteomics : McP. 12: 1621-31. PMID 23449826 DOI: 10.1074/Mcp.M112.026427 |
0.332 |
|
| 2013 |
Manasanch EE, Korde N, Yuan C, Kwok M, Tageja N, Bhutani M, Flanders AW, Zingone A, Costello R, Tembhare P, Mulquin M, Zuchlinski D, Maric I, Calvo KR, Steinberg SM, et al. Biologic variations of plasma cells in the bone marrow of smoldering multiple myeloma (SMM) and multiple myeloma (MM) patients: Multiple biopsies in the same patient. Journal of Clinical Oncology. 31: e19506-e19506. DOI: 10.1200/Jco.2013.31.15_Suppl.E19506 |
0.352 |
|
| 2013 |
Bhutani M, Costello R, Korde N, Manasanch EE, Kwok M, Tageja N, Mailankody S, Kazandjian D, Wu P, Zingone A, Burton D, Carter G, Zuchlinski D, Mulquin M, Maric I, ... Calvo KR, et al. Serum Heavy-Light Chains (HLC) and Free Light Chains (FLC) As Predictors For Early CR In Newly Diagnosed Myeloma Patients Treated With Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Blood. 122: 762-762. DOI: 10.1182/Blood.V122.21.762.762 |
0.334 |
|
| 2013 |
Korde N, Zingone A, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Costello R, Zhang Y, Burton D, Carter G, Wu P, Mulquin M, Zuchlinski D, ... ... Calvo KR, et al. Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients Blood. 122: 538-538. DOI: 10.1182/Blood.V122.21.538.538 |
0.374 |
|
| 2013 |
Larrea CFd, Zingone A, Manasanch EE, Korde N, Wu P, Costello R, Zuchlinski D, Mulquin M, Burton D, Maric I, Calvo KR, Stetler-Stevenson M, Yuan C, Roschewski M, Landgren O. Plasma Circulating Proteasomes As Biomarkers Along Natural History Of Asymptomatic Monoclonal Gammopathies Blood. 122: 3133-3133. DOI: 10.1182/Blood.V122.21.3133.3133 |
0.368 |
|
| 2013 |
Landgren O, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Zingone A, Costello R, Burton D, Zhang Y, Wu P, Carter G, Mulquin M, Zuchlinski D, ... ... Calvo KR, et al. Clinical and Correlative Pilot Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRd – R) In High Risk Smoldering Multiple Myeloma Patients Blood. 122: 1939-1939. DOI: 10.1182/Blood.V122.21.1939.1939 |
0.369 |
|
| 2013 |
Mailankody S, Korde N, Faham M, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Weng L, Moorhead M, Costello R, Zhang Y, Zingone A, Burton D, Wu P, ... ... Calvo KR, et al. Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone Blood. 122: 1902-1902. DOI: 10.1182/Blood.V122.21.1902.1902 |
0.382 |
|
| 2013 |
Manasanch EE, de Larrea CF, Zingone A, Korde N, Tageja N, Bhutani M, Kazandjian D, Wu P, Costello R, Burton D, Carter G, Zuchlinski D, Mulquin M, Maric I, Calvo KR, et al. Enzymatic Activities Of Circulating Plasma Proteasomes (cProt) In Newly Diagnosed Multiple Myeloma (NDMM) Patients Undergoing Treatment With Carfilzomib, Lenalidomide and Dexamethasone (CRd) Blood. 122: 1877-1877. DOI: 10.1182/Blood.V122.21.1877.1877 |
0.33 |
|
| 2013 |
Kurlander R, LI Y, Stetler-Stevenson M, Yuan C, Korde N, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Costello R, Zhang Y, Zingone A, Wu P, ... ... Calvo KR, et al. Evaluation Of Circulating Cell-Free VDJ DNA As a Marker For Monitoring Patients With Multiple Myeloma (MM) During Treatment With Carfilzomib, Lenalidomide and Dexamethasone, Blood. 122: 1868-1868. DOI: 10.1182/Blood.V122.21.1868.1868 |
0.347 |
|
| 2013 |
Bhutani M, Mena E, Maric I, Tan E, Korde N, Berg AR, Minter AR, Weiss BM, Lindenberg L, Turkbey B, Aras O, Steinberg S, Kemp T, Calvo KR, Choyke PL, et al. Abstract 369: Role of bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Cancer Research. 73: 369-369. DOI: 10.1158/1538-7445.Am2013-369 |
0.345 |
|
| 2012 |
Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. The Journal of Clinical Investigation. 122: 3692-704. PMID 22996659 DOI: 10.1172/Jci61623 |
0.359 |
|
| 2012 |
Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. The New England Journal of Medicine. 367: 11-9. PMID 22762314 DOI: 10.1056/Nejmoa1200931 |
0.378 |
|
| 2012 |
Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. American Journal of Hematology. 87: 916-22. PMID 22473867 DOI: 10.1002/Ajh.23174 |
0.331 |
|
| 2012 |
Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 119: 3330-2. PMID 22210875 DOI: 10.1182/Blood-2011-09-379339 |
0.326 |
|
| 2012 |
Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 97: 586-94. PMID 22102710 DOI: 10.3324/Haematol.2011.048132 |
0.32 |
|
| 2012 |
Calvo KR, Hickstein DD, Holland SM. MonoMAC and GATA2 deficiency: Overlapping clinical and pathological features with aplastic anemia and idiopathic CD4 + lymphocytopenia Haematologica. 97: 12-13. DOI: 10.3324/Haematol.2012.063396 |
0.352 |
|
| 2012 |
Korde N, Zingone A, Kwok M, Manasanch EE, Costello R, Zuchlinski D, Mulquin M, Maric I, Calvo KR, Braylan RC, Yuan C, Tembhare PR, Stetler-Stevenson M, Arthur DC, Raffeld M, et al. Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients Blood. 120: 732-732. DOI: 10.1200/Jco.2012.30.15_Suppl.E18568 |
0.377 |
|
| 2012 |
Kwok M, Korde N, Manasanch EE, Bhutani M, Maric I, Calvo KR, Zingone A, Costello R, Cherry BM, Yancey MA, Mulquin M, Roschewski MJ, Landgren O. Role of immune-related conditions in smoldering myeloma and MGUS. Journal of Clinical Oncology. 30: 8104-8104. DOI: 10.1200/Jco.2012.30.15_Suppl.8104 |
0.373 |
|
| 2012 |
Manier S, Sacco A, Maiso P, Zhang Y, Liu Y, Aljawai Y, Wang W, Corrigan-Cummins M, Leleu X, Calvo KR, Landgren O, Roccaro AM, Ghobrial I. Let-7 Microrna Family Members Regulate Cell Proliferation in Multiple Myeloma Blood. 120: 570-570. DOI: 10.1182/Blood.V120.21.570.570 |
0.311 |
|
| 2012 |
Tembhare PR, Yuan C, Korde N, Manasanch EE, Kwok M, Roschewski M, Maric I, Calvo KR, Mulquin M, Zuchlinski D, Landgren O, Stetler-Stevenson M. Peripheral Blood Involvement with Minimal Disease Is Common in Multiple Myeloma but Not in Smoldering Myeloma Blood. 120: 4994-4994. DOI: 10.1182/Blood.V120.21.4994.4994 |
0.328 |
|
| 2012 |
West RR, Hsu A, Calvo KR, Cuellar-Rodriguez J, Holland SM, Hickstein DD. ASXL1 mutations in GATA2-Deficiency Correlate with Leukemic Transformation Blood. 120: 405-405. DOI: 10.1182/Blood.V120.21.405.405 |
0.362 |
|
| 2012 |
Kwok ML, Korde N, Manasanch EE, Flanders AW, Maric I, Calvo KR, Zingone A, Costello R, Cordaro D, Sato A, Mulquin M, Zuchlinski D, Roschewski M, Landgren O. Altered Plasma Cell Characteristics in Smoldering Myeloma and MGUS Patients with Preceding Immune-Related Conditions Blood. 120: 4006-4006. DOI: 10.1182/Blood.V120.21.4006.4006 |
0.377 |
|
| 2012 |
Wang W, Corrigan-Cummins M, Vinh DC, Hsu AP, Hickstein DD, Holland SM, Calvo KR. MCL-1 and Mir-181c in GATA2 Mutation Associated Monomac and Familial Myelodysplastic Syndrome Blood. 120: 3807-3807. DOI: 10.1182/Blood.V120.21.3807.3807 |
0.312 |
|
| 2012 |
Korde N, Liu QY, Kwok M, Manasanch EE, Simakova O, Mailankody S, Roschewski M, Zingone A, Costello R, Zuchlinski D, Mulquin M, Calvo KR, Braylan RC, Maric I, Landgren O. Early Myelodysplastic Changes Present in Substantial Proportion of Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Patients Blood. 120: 1805-1805. DOI: 10.1182/Blood.V120.21.1805.1805 |
0.39 |
|
| 2012 |
Alter BP, Giri N, Calvo KR, Maric I, Arthur DC, Hickstein DD, Hastings CA, Lee MA, Hsu A, Holland SM. Clinically Silent Carriers in Families with Myelodysplastic Syndrome Due to GATA2 Mutations Blood. 120: 1264-1264. DOI: 10.1182/Blood.V120.21.1264.1264 |
0.37 |
|
| 2012 |
Johnson KD, Gao X, Sanalkumar R, Hsu AP, Ryu M, Wang J, Boyer ME, Liu Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. Genetic Determinants of the Definitive Hematopoietic Stem/Progenitor Cell Compartment Blood. 120: 1226-1226. DOI: 10.1182/Blood.V120.21.1226.1226 |
0.384 |
|
| 2012 |
Rao VK, Oliveira JB, Niemela J, Davis J, Price S, Kuehn H, Calvo KR, Pittaluga S, Werner EJ, Lee J, Barbour M, Natter M, Loh ML, Fleisher TA. Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML) Blood. 120: 1033-1033. DOI: 10.1182/Blood.V120.21.1033.1033 |
0.409 |
|
| 2011 |
Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, Hsu AP, Zerbe CS, Calvo KR, Wilder J, Kurlander R, Olivier KN, Holland SM, Hickstein DD. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood. 118: 3715-20. PMID 21816832 DOI: 10.1182/Blood-2011-06-365049 |
0.396 |
|
| 2011 |
Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 118: 2653-5. PMID 21670465 DOI: 10.1182/Blood-2011-05-356352 |
0.338 |
|
| 2011 |
Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 96: 1221-5. PMID 21508125 DOI: 10.3324/Haematol.2011.041152 |
0.402 |
|
| 2011 |
Maric I, Calvo KR. Mastocytosis: the new differential diagnosis of CD30-positive neoplasms. Leukemia & Lymphoma. 52: 732-3. PMID 21463113 DOI: 10.3109/10428194.2011.561389 |
0.361 |
|
| 2011 |
Olnes MJ, Scheinberg P, Calvo K, Tang Y, Soto S, Feng X, Desmond RG, Lozier JN, Young NS, Dunbar CE. Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial Blood. 118: 54-54. DOI: 10.1182/Blood.V118.21.54.54 |
0.407 |
|
| 2011 |
Costello R, Espana K, Korde N, Kwok M, Zingone A, Yancey MA, Mulquin M, Maric I, Calvo K, Tembhare PR, Yuan C, Stetler-Stevenson M, Landgren O. Hevylite™ Assays Detect a Hidden Immunoparesis Associated with Adverse Biology in Myeloma Precursor Disease: A Prospective Clinical Study Blood. 118: 5065-5065. DOI: 10.1182/Blood.V118.21.5065.5065 |
0.364 |
|
| 2011 |
Zingone A, Korde N, Chen J, Xi L, Raffeld M, Holkova B, Kmieciak M, Sullivan D, Doyle A, Maric I, Calvo K, Yancey MA, Mulquin M, Annunziata C, Grant S, et al. Molecular Characterization and Clinical Correlations of MEK1/2 Inhibition (AZD6244) in Relapse or Refractory Multiple Myeloma: Analysis From a Phase II Study Blood. 118: 306-306. DOI: 10.1182/Blood.V118.21.306.306 |
0.423 |
|
| 2011 |
Korde N, Trepel J, Carlsten M, Zingone A, Costello R, Yancey MA, Mulquin M, Maric I, Calvo K, Tembhare PR, Yuan C, Stetler-Stevenson M, Lee M, Alarcon S, Carter G, et al. A Phase II Trial of IPH2101 (anti-KIR mAb) in Smoldering Multiple Myeloma Blood. 118: 2944-2944. DOI: 10.1182/Blood.V118.21.2944.2944 |
0.4 |
|
| 2006 |
Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nature Methods. 3: 287-93. PMID 16554834 DOI: 10.1038/Nmeth865 |
0.73 |
|
| 2006 |
Mundinger GS, Espina V, Liotta LA, Petricoin EF, Calvo KR. Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray Targeted Oncology. 1: 151-167. DOI: 10.1007/S11523-006-0025-2 |
0.309 |
|
| 2005 |
Calvo KR, Liotta LA, Petricoin EF. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Bioscience Reports. 25: 107-25. PMID 16222423 DOI: 10.1007/S10540-005-2851-3 |
0.326 |
|
| 2004 |
Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Advances in Anatomic Pathology. 11: 227-38. PMID 15322489 DOI: 10.1097/01.Pap.0000138144.11635.F8 |
0.325 |
|
| 2002 |
Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 21: 4247-56. PMID 12082612 DOI: 10.1038/Sj.Onc.1205516 |
0.708 |
|
| 2001 |
Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13120-5. PMID 11687616 DOI: 10.1073/Pnas.231115398 |
0.7 |
|
| 2000 |
Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Molecular and Cellular Biology. 20: 3274-85. PMID 10757811 DOI: 10.1128/Mcb.20.9.3274-3285.2000 |
0.701 |
|
| 1999 |
Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 18: 8033-43. PMID 10637514 DOI: 10.1038/Sj.Onc.1203377 |
0.577 |
|
| 1997 |
Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proceedings of the National Academy of Sciences of the United States of America. 94: 14553-8. PMID 9405651 DOI: 10.1073/Pnas.94.26.14553 |
0.587 |
|
| Show low-probability matches. |